Whilst broadly, these studies demonstrate the potential for HDAC inhibition to effectively improve the sensitivity of cancer cells to radiotherapy, interestingly, this strategy has not been reportedly explored in HNSCC. The gene discussed is HDAC9; the disease is cancer.